These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18476915)

  • 1. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.
    Okada T; Nakao T; Matsumoto H; Shino T; Nagaoka Y; Tomaru R; Wada T
    Intern Med; 2007; 46(12):807-14. PubMed ID: 17575371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.
    Tang M; Berg AH; Zheng H; Rhee EP; Allegretti AS; Nigwekar SU; Karumanchi SA; Lash JP; Kalim S
    Am J Kidney Dis; 2024 Sep; 84(3):329-338. PubMed ID: 38518919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis.
    Shima K; Komatsu M; Kawahara K; Minaguchi J; Kawashima S
    Nephrology (Carlton); 2010 Sep; 15(6):632-8. PubMed ID: 20883284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
    Morioka T; Emoto M; Tabata T; Shoji T; Tahara H; Kishimoto H; Ishimura E; Nishizawa Y
    Diabetes Care; 2001 May; 24(5):909-13. PubMed ID: 11347753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
    Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
    Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis.
    Lu CL; Ma WY; Lin YF; Shyu JF; Wang YH; Liu YM; Wu CC; Lu KC
    Int J Med Sci; 2016; 13(5):395-402. PubMed ID: 27226780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
    Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
    J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis.
    Inaba M; Maekawa K; Okuno S; Imanishi Y; Hayashino Y; Emoto M; Shoji T; Ishimura E; Yamakawa T; Nishizawa Y
    Clin Nephrol; 2012 Oct; 78(4):273-80. PubMed ID: 22541674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
    Ishimura E; Okuno S; Kono K; Fujino-Kato Y; Maeno Y; Kagitani S; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
    Diabetes Res Clin Pract; 2009 Mar; 83(3):320-6. PubMed ID: 19135755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.